Abstract
New advances in diagnostic technologies in nuclear medicine and radiopharmaceutical development, has led to the introduction of some potent copper-radiopharmaceuticals used in the diagnosis and/or therapy of human diseases. Copper radio nuclides provide a series of therapeutic/diagnostic tracers suitable for radiolabeling of small molecules, peptides, antibody fragments and monoclonal antibodies. The current status of copper radiopharmaceuticals for imaging, therapy and research studies of oncological processes is reviewed here with a look into the future directions as the conclusion.
Keywords: Copper radiosiotopes, radiopharmaceuticals, diagnosis, therapy, PET
Current Radiopharmaceuticals
Title: Production and Application of Copper Radiopharmaceuticals
Volume: 2 Issue: 2
Author(s): Amir Reza Jalilian, Pejman Rowshanfarzad and Mahsheed Sabet
Affiliation:
Keywords: Copper radiosiotopes, radiopharmaceuticals, diagnosis, therapy, PET
Abstract: New advances in diagnostic technologies in nuclear medicine and radiopharmaceutical development, has led to the introduction of some potent copper-radiopharmaceuticals used in the diagnosis and/or therapy of human diseases. Copper radio nuclides provide a series of therapeutic/diagnostic tracers suitable for radiolabeling of small molecules, peptides, antibody fragments and monoclonal antibodies. The current status of copper radiopharmaceuticals for imaging, therapy and research studies of oncological processes is reviewed here with a look into the future directions as the conclusion.
Export Options
About this article
Cite this article as:
Jalilian Reza Amir, Rowshanfarzad Pejman and Sabet Mahsheed, Production and Application of Copper Radiopharmaceuticals, Current Radiopharmaceuticals 2009; 2 (2) . https://dx.doi.org/10.2174/1874471010902020092
| DOI https://dx.doi.org/10.2174/1874471010902020092 |
Print ISSN 1874-4710 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
Related Articles
-
A Pan-Cancer Review of <i>ALK</i> Mutations: Implications for Carcinogenesis and Therapy
Current Cancer Drug Targets Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
Current Cancer Drug Targets The Adenosine A2b Receptor: Its Role in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Clinical and Translational Research Challenges in Biliary Tract Cancers
Current Medicinal Chemistry Lyn Regulates Cytotoxicity in Respiratory Epithelial Cells Challenged by Cigarette Smoke Extracts
Current Molecular Medicine Intersection of MicroRNA and Gene Regulatory Networks and their Implication in Cancer
Current Pharmaceutical Biotechnology Death by Insulin: Management of Self-Harm and Suicide in Diabetes Management
Current Diabetes Reviews Genetic Polymorphism and Tumor Immunotherapy
Current Pharmacogenomics Estrogen Receptor Signaling: Impact on Cell Functions
Current Signal Transduction Therapy Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design Heterocyclic Moieties as HDAC Inhibitors: Role in Cancer Therapeutics
Mini-Reviews in Medicinal Chemistry ErbB Targeted Drugs and Angiogenesis
Current Vascular Pharmacology VK<sub>2</sub> Promotes Osteogenic Differentiation of BMSCs against High Glucose Exposure via Modulation of Intracellular Oxidative Stress
Current Pharmaceutical Design Integrin α4β7 Antagonists: Activities, Mechanisms of Action and Therapeutic Prospects
Current Immunology Reviews (Discontinued) Medical Image Processing based on Generative Adversarial Networks: A Systematic Review
Current Medical Imaging Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer
Current Pharmaceutical Design Light Alcohol Drinking and the Risk of Cancer Development: A Controversial Relationship
Reviews on Recent Clinical Trials New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
Current Pharmaceutical Design Neurochemical Markers in the Mammalian Brain: Structure, Roles in Synaptic Communication, and Pharmacological Relevance
Current Medicinal Chemistry Caveolae and Caveolin-1: Novel Potential Targets for the Treatment of Cardiovascular Disease
Current Pharmaceutical Design





